Carregant...

Development of a peptide by phage display for SPECT imaging of resistance-susceptible breast cancer

Personalized medicine is at the forefront of cancer diagnosis and therapy. Molecularly targeted therapies such as trastuzumab and tamoxifen have enhanced prognosis of patients with cancers expressing ERBB2 and the estrogen receptor, respectively. One obstacle to targeted therapy is the development o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Larimer, Benjamin M, Deutscher, Susan L
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4138138/
https://ncbi.nlm.nih.gov/pubmed/25143862
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!